Related Experiment Videos

[Phlebographic follow-up of successful fibrinolytically-treated deep thrombophlebitis]

B Eickerling1, H Rakus, M Martin

  • 1Geriatrische Klinik, Städtischen Kliniken Duisburg.

Insights

Long-term results show fibrinolytic treatment for deep vein thrombosis has a low reocclusion rate. This suggests fibrinolysis is a viable treatment option for venous occlusions.

Area of Science:

  • Vascular Surgery
  • Thrombolytic Therapy

Context:

  • Deep venous occlusions (DVO) pose significant health risks.
  • Fibrinolytic therapy offers a potential treatment for DVO.
  • Evaluating long-term outcomes of fibrinolysis is crucial for clinical practice.

Purpose:

  • To assess the long-term efficacy and safety of fibrinolytic treatment for deep venous occlusions.
  • To determine the reocclusion rates in patients treated with an ultrahigh streptokinase regimen.

Summary:

  • This study evaluated 27 patients with deep venous occlusions treated with fibrinolysis.
  • Follow-up averaged 18.9 months. Reocclusion rates were 9.5% for femoral vein thrombosis and 0% for iliac vein thrombosis.
  • One case of late thrombus lysis was observed.

Impact:

  • Fibrinolytic treatment demonstrates a low tendency for venous reocclusion after successful thrombolysis.
  • These findings support fibrinolysis as an effective therapeutic strategy for deep vein thrombosis.
  • The study encourages further consideration of fibrinolytic therapy in managing venous thromboembolic disease.

Related Concept Videos